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Background: The present study investigated plasma levels of gut-brain axis peptides ghrelin, obestatin, NPY and
PYY after consumption of a high-carbohydrate (HC) and high-protein (HP) breakfast in patients with anorexia
nervosa, bulimia nervosa and in healthy controls. These peptides play an important role in regulation of energy
homeostasis and their secretion is disturbed under condition of eating disorders. As various types of consumed
macronutrients may induce different plasma hormone responses, so we examined these responses in women
patients with eating disorders and compared them with those of healthy controls.
Methods: We examined plasma hormone responses to HC and HP breakfast in patients with AN (n = 14; age:
24.6 ± 1.8 years, BMI: 15.3 ± 0.7), BN (n = 15; age: 23.2 ± 1.7 years, BMI: 20.5 ± 0.9) and healthy controls (n = 14; age:
24.9 ± 1.4 years, BMI: 21.1 ± 0.8). Blood samples were drawn from the cubital vein, the first blood drawn was
collected before meal, and then 30, 60, 90, 120 and 150 min after breakfast consumption. Plasma hormone levels
were determined by commercially available RIA kits.
Results: Fasting and postprandial plasma obestatin levels were significantly increased in both AN and BN patients,
while plasma ghrelin levels were significantly increased in AN patients only. After breakfast consumption, plasma
levels of ghrelin and obestatin decreased, although they were still above the range of values of healthy controls.
Fasting NPY plasma levels were significantly increased in AN and BN patients and did not change postprandially.
Fasting PYY levels were comparable in AN, BN and healthy controls, but postprandially significantly increased after
HP breakfast in AN and BN patients. Different reactions to breakfast consumption was found for ghrelin and PYY
among investigated groups, while for obestatin and NPY these reactions were similar in all groups.
Conclusions: Significant increase of obestatin and NPY in AN and BN patients may indicate their important role as
the markers of eating disorders. Different reactions of ghrelin and PYY to breakfast consumption among groups
suggest that role of these hormones in regulation of energy homeostasis can be adjusted in dependence to acute
status of eating disorder.
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Food intake and appetite are controlled by hypothal-
amus, where nucleus arcuatus (ARC) through interaction
of peripheral hormonal and metabolic signals control all
processes relating to energy balance. Peptides of gut-
brain axis play a pivotal role in regulation of energy
homeostasis and their secretion is disturbed under con-
dition of eating disorders, including anorexia nervosa
(AN) and bulimia nervosa (BN). These psychiatric and
somatic diseases are characterized by abnormal eating
behaviour and imbalance in energy homeostasis. Neuro-
peptide Y (NPY) has a number of important functions in
regulation of appetite and energy homeostasis [1]. NPY
neurons in the hypothalamic ARC play a central role in
stimulation of feeding, they sense and integrate periph-
eral and central signals, including ghrelin and leptin [2].
Ghrelin is a peptide produced mainly by stomach, which
as appetite-stimulating hormone transmits changes in
food intake to the central nervous system [3]. The effect
of ghrelin is related to the antagonism of the inhibitory
effect of leptin on hypothalamic NPY production [4-6].
A novel peptide hormone obestatin, derived from the
same gene as ghrelin, has been initially postulated to
antagonize ghrelin actions on energy homeostasis and
gastrointestinal functions [7-9], however the most of
subsequent studies could not confirm its reported anor-
exigenic effects [10-13]. Plasma levels of these hormones,
both fasting and postprandial, were investigated in AN
and BN patients. Most of previous studies reported
increased fasting plasma ghrelin levels in AN patients
[3,14-17] and recent studies also presented increased
fasting plasma obestatin levels in these patients [17,18].
In BN patients were reported either no changes in fast-
ing ghrelin or increased plasma ghrelin levels, compared
to healthy controls [15,19,20]. Monteleone et al. (2008)
did not find any increase in fasting obestatin plasma
levels in BN patients [17]. However, in our previous
study, we found increased fasting plasma ghrelin levels
only in AN patients while obestatin levels were elevated
in both group of patients with AN and BN [21]. Peptide
YY (PYY) is a member of the pancreatic polypeptide
family, which has been reported to reduce food intake
[22]. It is suggested that peripheral PYY acts as a satiety
signal regulating the termination of individual meals,
partially by decreasing the production of the hunger-
stimulating peptide ghrelin [17]. Fasting PYY levels have
been reported to be low in healthy people [23,24], nor-
mal [25] or increased [26-28] in AN patients and normal
in BN patients [20,23]. Leptin is a peptide hormone,
secreted mainly by adipose tissue, which influences long-
term energy homeostasis. Decreased leptin levels were
measured in AN patients with undernutrition [19,29].
All introduced hormones are involved in regulation of
food intake and energy homeostasis, either in acute(ghrelin, obestatin, PYY) or long-term changes (leptin,
NPY). The effect of specific macronutrients (carbohy-
drates, proteins, fat) on secretion of above mentioned
hormones has been partially investigated in humans.
However, results reported in individual studies are very
different, especially in studies aimed to patients with eat-
ing disorders. Prince et al. compared the results of stud-
ies concerned to gut hormone levels in patients with
eating disorders, with general conclusion that these
patients had higher baseline concentrations of ghrelin
and PYY. No differences were found in release of these
hormones to a standardized test meal, when compared
to healthy controls [30].
To our knowledge, no study has measured simultan-
eously pre- and postprandial secretion of ghrelin, obesta-
tin, NPY, PYY and leptin in patients with AN and BN.
Therefore the aim of present study was to investigate
plasma levels of these hormones after consumption of
two meals with different content of macronutrients
(high-protein and high-carbohydrate breakfast) in
patients with AN, BN and healthy women. We investi-
gated if plasma hormone responses are different after
consumption of high-protein and high-carbohydrate
breakfast within the observed groups. Simultaneously,
we compared if plasma hormone responses to the same




This study was performed in accordance with the Decla-
ration of Helsinki and was approved by Ethic Committee
of Institute of Endocrinology in Prague. All participants
undersigned informed consent prior to the study. Fourteen
patients with AN, both restrictive and purgative type (age:
24.6 ± 1.8 years, BMI: 15.3± 0.7), fifteen women with BN
(age: 23.2± 1.7 years, BMI: 20.5 ± 0.9) and fourteen healthy
controls (age: 24.9± 1.4 years, BMI: 21.1 ± 0.8 kg/m2) were
enrolled in the study. Healthy controls (C) were recruited
from university students, age-matched to AN and BN
patients. They had no history of eating disorders, had nor-
mal electrocardiogram (ECG), blood count, liver and renal
functions. Blood tests and physical examination were con-
ducted before the test. All healthy women had regular
menstrual cycle and were in follicular phase of the cycle at
the time of study. AN and BN patients were diagnosed
according to the 4th edition of the Diagnostic and Statis-
tical Manual of Mental Disorders, American Psychiatric
Association, 1994. All AN and BN patients were clinically
stable and in relatively good health, except for their eating
disorder and amenorrhea. All patients were investigated
after 1 week of hospitalization at the Department of
Psychiatry at Charles University, Prague. Blood tests con-
ducted before initiation of the study confirmed normal
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renal functions.
Participants were recommended to avoid vigorous
physical activity during the 14-hour period before blood
samplings. All subjects consumed a standardized dinner
at 6.00 PM and were then asked to fast overnight.
Reported duration of sleep in the night preceding blood
sampling was comparable in all studied groups. All par-
ticipants were admitted to the Institute of Endocrin-
ology at 7.30 AM. The study lasted about 3.5 hours
and the protocol consisted of high-carbohydrate
breakfast consumption and blood withdrawals. One
week later, all patients were investigated again and
they received high-protein breakfast with the same
study protocol. Body composition was measured using
method of bioimpedance [Tanita, Japan] together with
other physical examination before the beginning of
both breakfasts.
Study design
Each participant received a high-carbohydrate breakfast
(HC) with a total energy content of 1604 kJ, consisting
of 81.9 g carbohydrates, 8.8 g proteins and 3.4 g fats
in the form of a white bread roll (90 g) and strawberry
jam (50 g) [21]. One week later, each participant
received a high-protein breakfast (HP) with a total en-
ergy content of 1350 kJ, consisting of 41.3 g proteins,
16.3 g carbohydrates and 8.1 g fat in the form of a cot-
tage cheese (150 g), chicken ham (75 g) and wheat
store-bread (15 g). In addition, the subjects consumed
250 ml of fruit tea without sugar or other sweetener
together with the meal. Participants had 15 minutes
time- limit to consume their meal. Blood samples were
drawn from the cubital vein using an intravenous can-
nula, the first blood drawn was collected before meal,
and then 30, 60, 90, 120 and 150 min after breakfast
consumption. Blood samples were collected into chilled
polypropylene tubes containing Na2EDTA and antilysin.
Plasma was immediately separated by 15-min centrifu-
gation at 5°C and stored at −70°C until being assayed
[21].
Analytical measurements
Total plasma ghrelin and NPY were determined by com-
mercially available RIA kits (Linco Research, Inc., St.
Charles, Missouri, U.S.A.). The intra- and interassay for
total ghrelin was 6.4% and 16.3%, sensitivity was 93 pg/
mL, for NPY the intra- and interassay was 5.0% and
8.4% respectively, sensitivity was 3 pmol/L. Plasma obes-
tatin was measured by a commercial RIA kit (Phoenix
Pharmaceuticals Inc., Belmont, CA, U.S.A.), the intra-
and interassay variability was 5.0% and 14.2%, respect-
ively, sensitivity was 50 pg/mL. Plasma PYY was
determined by commercially available RIA kit (LincoResearch, Inc., St. Charles, Missouri, U.S.A.). The intra-
and interassay for total PYY was 5.8% and 13.9%, sensi-
tivity was 72 pg/mL.
Statistical data analysis
The dependence of metric variables on factors was
evaluated using repeated measures ANOVA model
consisting of subject factor, repeated and non-repeated
factors and interaction between factors. Least signifi-
cant difference multiple comparisons followed the
ANOVA testing. The level of statistical significance
P< 0.05 was chosen for both ANOVA and multiple
comparisons. Due to non-Gaussian data distribution in
all dependent variables these underwent power trans-
formations to attain distributional symmetry and a con-
stant variance both in the data and residuals. Data
transformation and analysis of variance was performed
using Statgraphics Centurion version XV software
(Statpoint Inc, Herndon, Virginia, USA). The relation-
ships between variables were evaluated using multivariate
regression after transformation of variables to symmetry
and constant variance. The statistical software SIMCA
v. 12.0 from Umetrics (Umeå, Sweden) was used for
data analysis.
Results
The fasting plasma levels of ghrelin, obestatin, NPY and
PYY and their postprandial responses after high-
carbohydrate (HC) and high-protein (HP) breakfast con-
sumption are presented in Figures 1, 2, 3 and 4 for all
investigated groups.
Ghrelin
Fasting and postprandial plasma ghrelin levels were sig-
nificantly increased in AN patients compared to the con-
trols and BN patients. After both types of breakfast,
plasma ghrelin levels significantly decreased, with mini-
mum at 90 min after HC breakfast and 30 min after HP
breakfast. Factor “breakfast” was not significant in AN
patients, but interaction “breakfast” x “time (stage of the
meal test)” showed different course of ghrelin in time
after HC and HP breakfast. In BN patients, fasting and
postprandial levels of ghrelin were comparable to values
of healthy controls. After both types of breakfast, plasma
ghrelin levels decreased, however this decrease was sig-
nificant only after HC breakfast. Minimum ghrelin
values were reached 90 min after HC breakfast and
30 min after HP breakfast (equally, as in AN patients).
The course of ghrelin after both types of breakfast was
different after HC and HP breakfast in BN patients. In
healthy control women, plasma ghrelin levels signifi-
cantly decreased after both types of breakfast with mini-
mum at 120 min after HC breakfast and 60 min after





















Time [min] Time [min] Time [min] 
Controls
Factor F-Ratio p-value
Status (A) 568.5 0.0000
Subject (B) 73.1 0.0000
Breakfast (C) 60.6 0.0000







Subject (B) 41.3 0.0000
Breakfast (C) 29.0 0.0000

























Subject (B) 113.8 0.0000
Breakfast (C) 0.9 0.3574

























Subject (B) 75.1 0.0000
Breakfast (C) 38.8 0.0000
Time (D) 4.0 0.0018
C×D 4.2 0.0012
ANOVA, Bulimia
Figure 1 Plasma levels of ghrelin during the meal test. The circles, triangles and squares with error bars represent the retransformed means
with their 95% confidence intervals for controls (C), patients suffering with anorexia nervosa (AN), and patients suffering with bulimia nervosa (BN),
respectively as evaluated by repeated measures ANOVA followed by least significant difference multiple comparisons. For the details see Statistical
data analysis. High-carbohydrate breakfast is marked by empty symbol (○, △, □), high-protein breakfast is marked by full symbol (●,▲, ■).
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fast” in overall ANOVA, the ghrelin reaction was differ-
ent after HC and HP breakfast consumption among
investigated groups.
Obestatin
Fasting plasma obestatin levels were found significantly
increased in both AN and BN patients compared to the
controls. The highest basal values were observed in AN
patients, similarly as plasma ghrelin values. In these
patients plasma obestatin levels decreased significantly
after both types of breakfast, with minimum at 90 min
after HC and 30 min after HP breakfast. Neither factor
“breakfast” nor interaction “breakfast” x “time” were sig-
nificant in AN patients, and therefore no difference was
found in ghrelin reaction in time after HC and HP
breakfast consumption. In BN patients, plasma obestatin
levels decreased significantly after both types of break-
fast, with minimum values at 90 min after HC breakfast
and 150 min after HP breakfast. As documented by sig-
nificant factor “breakfast“ and interaction “breakfast” x
“time”, course of obestatin after both types of breakfastwas different in BN patients. In healthy control group,
plasma obestatin levels also significantly decreased after
both HC and HP breakfast consumption and course of
obestatin was different in time. The obestatin reaction
after HC and HP breakfast was similar in all groups, al-
though plasma levels had different range of values, as
documented by interaction “status” x “breakfast” in over-
all ANOVA.
NPY
Fasting and postprandial plasma levels of NPY were sig-
nificantly increased in AN and BN patients compared to
the controls. No changes were found postprandially in
AN patients after both types of breakfast, but in BN
patients and healthy controls plasma NPY decreased
after HC breakfast. After HP breakfast consumption no
significant changes were found. However, as indicated by
interaction “breakfast” x “time”, the course of NPY after
HC and HP breakfast consumption was not significantly
different in all investigated groups. Also no differences























Time [min] Time [min] Time [min] 
Controls
Factor F-Ratio p-value
Status (A) 953.7 0.0000









Subject (B) 156.0 0.0000
Breakfast (C) 35.2 0.0000


























Subject (B) 179.5 0.0000
Breakfast (C) 3.2 0.0799


























Subject (B) 192.2 0.0000




Figure 2 Plasma levels of obestatin during the meal test. The circles, triangles and squares with error bars represent the retransformed
means with their 95% confidence intervals for controls (C), patients suffering with anorexia nervosa (AN), and patients suffering with bulimia
nervosa (BN), respectively as evaluated by repeated measures ANOVA followed by least significant difference multiple comparisons. For the details
see Statistical data analysis. High-carbohydrate breakfast is marked by empty symbol (○, △, □), high-protein breakfast is marked by full symbol
(●, ▲, ■).
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Fasting plasma levels of PYY were found in similar range
of values for all investigated groups. However, significant
differences were found in postprandial responses of PYY
to HC and HP breakfast in patients with AN and BN
compared to the controls. In AN and BN groups, plasma
PYY levels reached significantly higher values after HP
breakfast compared to HC breakfast, with maximum in
120 min for AN and 90 min for BN. In healthy control
group, postprandial increase was also observed after HP
breakfast, however this increase was not significant and
reached values were significantly lower than plasma PYY
levels in AN and BN groups. As documented by signifi-
cant interaction “status” x “breakfast” in overall ANOVA,
the PYY course after HC and HP breakfast was different
among investigated groups.Leptin
Basal plasma levels of leptin were found significantly lower
in AN and BN patients compared to healthy women. We
found no changes in leptin levels postprandially eitherafter HC or HP breakfast consumption in all investigated
groups.
Correlations
Status of anorexia nervosa was found to be positively
correlated with plasma levels of ghrelin, obestatin, NPY
and PYY and negatively correlated with BMI, percent of
body fat and weight. Status of bulimia nervosa was
found to be positively correlated with plasma levels of
NPY, obestatin and PYY, and negatively with leptin
levels.
Discussion
This study was designed to investigate the plasma
responses of ghrelin, obestatin, NPY and PYY after high-
carbohydrate and high-protein breakfast consumption in
AN and BN patients and in healthy women. We found
fasting plasma obestatin levels significantly increased in
AN and BN patients, while ghrelin levels were increased
only in AN patients. Postprandially, we observed signifi-
cant decrease in plasma ghrelin levels after both types of





















Status (A) 314.3 0.0000
Subject (B) 29.5 0.0000
Breakfast (C) 12.3 0.0005







Subject (B) 49.3 0.0000
Breakfast (C) 0.7 0.4211























Subject (B) 13.6 0.0000
Breakfast (C) 2.4 0.1268























Subject (B) 34.1 0.0000
Breakfast (C) 12.4 0.0007
Time (D) 2.2 0.0915
C×D 1.4 0.2493
ANOVA, Bulimia
Figure 3 Plasma levels of NPY during the meal test. The circles, triangles and squares with error bars represent the retransformed means with
their 95% confidence intervals for controls (C), patients suffering with anorexia nervosa (AN), and patients suffering with bulimia nervosa (BN),
respectively as evaluated by repeated measures ANOVA followed by least significant difference multiple comparisons. For the details see Statistical
data analysis. High-carbohydrate breakfast is marked by empty symbol (○, △, □), high-protein breakfast is marked by full symbol (●,▲, ■).
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observed in all investigated groups. Regarding obestatin
levels, they also decreased postprandially after both types
of breakfast in all investigated groups. In BN patients
and healthy controls the reaction of obestatin was differ-
ent to HC and HP breakfast, however in AN patients no
difference was found.
Our results for fasting ghrelin and obestatin levels in
AN patients and healthy controls are consistent with
present findings of other authors. Recent studies showed
increased plasma obestatin and ghrelin levels in AN
patients [18,26,31]. Monteleone et al. (2008) found
increased fasting plasma obestatin levels in AN patients,
however in BN patients obestatin levels were compar-
able to healthy controls [17]. In our previous study, we
demonstrated for the first time that plasma obestatin
levels significantly decrease after consumption of a high-
carbohydrate breakfast in a similar way as ghrelin levels
in healthy women [32]. Results of present study corres-
pond with our previous findings and were confirmed
also for AN and BN patients, independently on the type
of consumed breakfast. This positive relationship ofobestatin and ghrelin in postprandial period indicates
that these two cleavage products of preproghrelin act in
a similar way to increase food intake. Comparison of
hormone responses to HC and HP breakfast confirmed
mostly different reaction of these hormones in time to
the type of macronutrient. During comparison of groups,
similar reactions to food intake were confirmed for obes-
tatin in AN patients, BN patients and healthy women,
however the values of plasma obestatin were different.
Contrary, ghrelin responses to food intake were different
among groups.
NPY plays a central role in stimulation of feeding and
regulation of energy homeostasis. We found fasting
plasma levels of NPY significantly higher in AN and BN
patients, when compared to the healthy controls. This
finding is partially in accordance with studies of other
authors, where NPY levels were reported to be both
increased [33,34] and decreased [35] in AN patients.
Plasma NPY levels in our study showed no difference in
time to HC or HP breakfast in all groups. Overall ana-
lysis for all groups showed that reaction of plasma NPY to
























Status (A) 57.1 0.0000
Subject (B) 25.7 0.0000
Breakfast (C) 100.0 0.0000







Subject (B) 9.4 0.0000
Breakfast (C) 4.9 0.0302


























Subject (B) 22.5 0.0000
Breakfast (C) 42.4 0.0000


























Subject (B) 49.7 0.0000
Breakfast (C) 98.7 0.0000
Time (D) 11.5 0.0000
C×D 6.5 0.0000
ANOVA, Bulimia
Figure 4 Plasma levels of PYY during the meal test. The circles, triangles and squares with error bars represent the retransformed means with
their 95% confidence intervals for controls (C), patients suffering with anorexia nervosa (AN), and patients suffering with bulimia nervosa (BN),
respectively as evaluated by repeated measures ANOVA followed by least significant difference multiple comparisons. For the details see Statistical
data analysis. High-carbohydrate breakfast is marked by empty symbol (○, △, □), high-protein breakfast is marked by full symbol (●,▲, ■).
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any response of NPY to carbohydrate and protein meal
in healthy controls or AN and BN patients, therefore
we have no possibility to compare our findings. Produc-
tion of leptin correlates positively with adipose tissue
mass and circulating leptin levels, and thus reflects en-
ergy stores of organism. In our study fasting plasma lep-
tin levels were significantly lower in AN and BN
patients and no changes in were found postprandially.
Circulating PYY levels are low in the fasting state
and rapidly increase postprandially when two forms,
PYY1-36 and PYY3-36 are released to circulation. In
our study we observed significant increase in postpran-
dial plasma levels in AN and BN patients after HP
breakfast, much higher than those in healthy controls.
This suggests strong influence of macronutrient type
to postprandial secretion of PYY in patients with eat-
ing disorders. These results partially correspond with
study of Nakahara et al. (2007), where PYY3-36 plasma
levels were increased after standard meal consumption
in both AN patients and healthy controls [26]. Our
results are also partly in accordance with review ofPrince at al. (2009), where patients with eating disor-
ders had higher baseline concentrations of PYY and
ghrelin [30]. In contrast, in study of Stock et al. (2005)
PYY increased significantly in the controls, but not in
AN patients [36]. In BN patients, initial studies
reported normal plasma levels of PYY. Recently, two
independent research groups have reported a blunted
PYY3-36 response to food ingestion in symptomatic
BN women together with a decreased response of
ghrelin [20,23]. Both studies have shown a negative
correlation between meal-induced PYY increase and
ghrelin decrease, confirming a negative interaction of
PYY3-36 with ghrelin [17].
Correlations between status of eating disorder and
investigated hormones were evaluated. As status of anor-
exia nervosa was found to be positively correlated with
plasma levels of ghrelin, obestatin, NPY and PYY, we
suppose that all these hormones are included in path-
ology of eating disorder and their levels are changed
probably as a consequence of eating disorder. Status of
bulimia nervosa was found to be positively correlated
with plasma levels of NPY, obestatin and PYY and
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mon with status of anorexia nervosa, at least regarding
behavior of plasma hormones and disturbed regulation
of energy homeostasis.
Conclusions
In conclusion, we demonstrated that significant differ-
ences exist in hormonal responses of ghrelin, obestatin
and PYY to a high-carbohydrate and high-protein break-
fast consumption within investigated groups. Increased
fasting plasma levels of NPY and obestatin were con-
firmed in AN and BN groups, which suggest a role of
these hormones as a markers for eating disorders. PYY
levels reached much higher values after high-protein
breakfast in AN and BN patients, indicating an import-
ant role of ingested macronutrient to plasma levels of
this hormone. Different reactions of ghrelin and PYY to
breakfast consumption were found among investigated
groups.
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